CN105169203A - Fructus amomi extract and application thereof - Google Patents
Fructus amomi extract and application thereof Download PDFInfo
- Publication number
- CN105169203A CN105169203A CN201510617335.2A CN201510617335A CN105169203A CN 105169203 A CN105169203 A CN 105169203A CN 201510617335 A CN201510617335 A CN 201510617335A CN 105169203 A CN105169203 A CN 105169203A
- Authority
- CN
- China
- Prior art keywords
- amomum
- volatile oil
- extract
- distilled water
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及药品和保健品领域,具体涉及一种砂仁提取物及其用途。The invention relates to the field of medicines and health care products, in particular to an amomum extract and its application.
背景技术Background technique
肥胖症(obescity)是指人体进食的热量多于消耗热量时,多余的热量以脂肪形式储存在体内,导致体内脂肪堆积过多和(或)分布异常,进而导致体重增加的一种多因素慢性代谢疾病。据WHO统计,现全球肥胖症患者已经超过3亿人,11亿人体重过重,因“吃”致病乃至死亡的人数已高于因饥饿死亡的人数。中国的肥胖症患者已超过七千万人,列在全球肥胖病发病率排行榜第10位。有关专家预测未来10年内,我国的肥胖人群可能超过两亿。总所周知,肥胖症与心脑血管疾病、高血压、2型糖尿病、血脂紊乱、睡眠呼吸暂停综合征等疾病的发生发展有着密切的关系。更为严峻的是,肥胖可引起其它器官如心、血管、肺的继发病,并可缩短预期寿命。据调查表明,肥胖人群的平均寿命明显地低于正常体重的人群。因此肥胖被评为健康的危险因素,对人类健康和社会发展构成严重威胁,研究开发相应的预防治疗手段成为迫切的需要。然而,目前市场上常用的减肥产品主要为食欲控制类、泻药、利尿剂、增加代谢类等,虽短时间内解决了肥胖问题,但因很多产品含有对人体有害成分,实则更不利于人体健康。因此迫切希望获得一种效果优良的减肥产品。Obesity (obesity) refers to a multifactorial chronic disease that occurs when the body eats more calories than it consumes, and the excess calories are stored in the body in the form of fat, resulting in excessive accumulation and/or abnormal distribution of body fat, which in turn leads to weight gain. metabolic disease. According to WHO statistics, there are now more than 300 million obese people in the world, and 1.1 billion people are overweight. The number of obese patients in China has exceeded 70 million, ranking 10th in the list of obesity incidence in the world. Relevant experts predict that in the next 10 years, the number of obese people in my country may exceed 200 million. As we all know, obesity is closely related to the occurrence and development of diseases such as cardiovascular and cerebrovascular diseases, hypertension, type 2 diabetes, dyslipidemia, and sleep apnea syndrome. What's more serious is that obesity can cause secondary diseases of other organs such as the heart, blood vessels, and lungs, and can shorten life expectancy. According to surveys, the average life expectancy of obese people is significantly lower than that of normal weight people. Therefore, obesity is rated as a health risk factor and poses a serious threat to human health and social development. Research and development of corresponding prevention and treatment methods have become an urgent need. However, the weight loss products commonly used in the market are mainly appetite control products, laxatives, diuretics, and metabolism-enhancing products. Although the obesity problem has been solved in a short period of time, many products contain harmful ingredients, which are actually even more harmful to human health. . Therefore urgently hope to obtain a kind of weight loss product with excellent effect.
砂仁(AmomiFructus)作为我国“四大南药”之一,有着1300多年的药用及食用历史。砂仁为姜科豆蔻属多年生草本植物,性温,味辛,具有化湿开胃、温脾止泻、理气安胎等功效是中医治疗肠胃疾病的常用药。现代药理研究表明砂仁中的主要有效成分包括乙酸龙脑酯、樟脑、柠檬烯、龙脑等挥发性物质,具有改善胃肠机能、止痛、止泻、促进消化液的分泌、降低血脂、调节肠道菌群等作用。砂仁作为常用的药用及食用药材经过长年临床实践与现代研究表明该药材具有毒副作用小,药效显著的优点。Amomi Fructus, as one of the "four major southern medicines" in my country, has a medicinal and edible history of more than 1300 years. Amomum is a perennial herb of the genus Cardamom in the ginger family. It is warm in nature and pungent in taste. It has the functions of reducing dampness and appetizing, warming the spleen and stopping diarrhea, regulating qi and preventing miscarriage. It is a commonly used medicine for treating gastrointestinal diseases in traditional Chinese medicine. Modern pharmacological studies have shown that the main active ingredients in amomum include borneol acetate, camphor, limonene, borneol and other volatile substances, which can improve gastrointestinal function, relieve pain, stop diarrhea, promote the secretion of digestive juice, reduce blood lipids, and regulate bowel movements. Tract flora etc. As a commonly used medicinal and edible medicinal material, many years of clinical practice and modern research have shown that the medicinal material has the advantages of less toxic and side effects and significant efficacy.
目前很多减肥产品具有副作用大和不良反应较多的问题,因此针对上述问题我们希望可以提供一种毒副作用小,减肥效果较为优异的纯天然减肥产品。At present, many weight loss products have the problems of large side effects and many adverse reactions. Therefore, we hope to provide a pure natural weight loss product with less toxic side effects and excellent weight loss effect in view of the above problems.
发明内容Contents of the invention
本发明的目的是:克服目前很多减肥产品副作用大和不良反应较多的问题,提供一种毒副作用小,减肥效果较为优异的纯天然减肥产品砂仁水提物和砂仁挥发油。The purpose of the present invention is to overcome the problems of large side effects and many adverse reactions of many current weight loss products, and provide a pure natural weight loss product Amomum water extract and Amomum volatile oil with less toxic side effects and excellent weight loss effect.
本发明的另一个目的是提供一种将上述减肥产品的制成制剂的方法。Another object of the present invention is to provide a method for preparing the above slimming product.
本发明解决该技术问题的技术方案是:The technical scheme that the present invention solves this technical problem is:
砂仁水提物的制备方法包括以下步骤:将砂仁粉碎后精密称取50-150g,加蒸馏水250-1000ml浸泡半小时,煮沸后文火煎5-10分钟,过滤药液,得到滤液A和药渣A;药渣A加蒸馏水再煎煮5-10分钟,过滤药液,得到滤液B和药渣B;药渣B加蒸馏水再煎煮5-10分钟,过滤药液,得到滤液C;合并滤液A、B、C,浓缩,冻干,即为砂仁水提物。The preparation method of Amomum water extract comprises the following steps: crush Amomum and accurately weigh 50-150g, add 250-1000ml of distilled water to soak for half an hour, boil and decoct with low heat for 5-10 minutes, filter the medicinal liquid to obtain filtrate A and Medicinal residue A; medicinal residue A is decocted with distilled water for 5-10 minutes, and the liquid medicine is filtered to obtain filtrate B and medicinal residue B; medicinal residue B is added with distilled water and decocted for 5-10 minutes, and the medicinal liquid is filtered to obtain filtrate C; The filtrates A, B, and C were combined, concentrated, and freeze-dried to obtain the water extract of Amomum japonicus.
砂仁挥发油的制备方法包括以下步骤:将砂仁粉碎后精密称取50-150g置于圆底烧瓶中,加蒸馏水200-800ml,浸泡0.5-1小时,采用水蒸气蒸馏法提取5-10h,收集挥发油,即为砂仁挥发油。The preparation method of Amomum volatile oil comprises the following steps: accurately weigh 50-150g of amomum and place it in a round-bottomed flask, add 200-800ml of distilled water, soak for 0.5-1 hour, extract by steam distillation for 5-10h, Collect the volatile oil, which is Amomum volatile oil.
本发明还提供了含砂仁提取物的制剂,由砂仁提取物和药学上可接受的载体组成。The invention also provides a preparation containing the Amomum extract, which consists of the Amomum extract and a pharmaceutically acceptable carrier.
所述制剂为片剂、胶囊或颗粒剂、口服液、注射液。The preparation is tablet, capsule or granule, oral liquid and injection.
所述药学上可接受的载体是指药学领域常见的药物载体,选自表面活性剂、填充剂、助悬剂、溶剂、矫味剂、粘合剂、崩解剂、润湿剂或润滑剂中的一种或几种。The pharmaceutically acceptable carrier refers to a common drug carrier in the field of pharmacy, selected from surfactants, fillers, suspending agents, solvents, flavoring agents, binders, disintegrating agents, wetting agents or lubricants one or more of them.
所述填充剂选自蔗糖、糊精、乳糖、甘露醇、淀粉、木糖醇、葡糖糖等;The filler is selected from sucrose, dextrin, lactose, mannitol, starch, xylitol, glucose, etc.;
所述粘合剂选自藻酸盐、淀粉、糊精、明胶或聚乙烯吡咯烷酮等;The binder is selected from alginate, starch, dextrin, gelatin or polyvinylpyrrolidone, etc.;
所述崩解剂选自羟甲基淀粉钠、低取代羟丙基纤维素、微晶纤维素或教练羟甲基纤维素钠;The disintegrating agent is selected from sodium hydroxymethyl starch, low-substituted hydroxypropyl cellulose, microcrystalline cellulose or sodium hydroxymethyl cellulose;
所述润滑剂选自聚乙二醇、碳酸氢钠、微粉硅胶、硬脂酸或硬脂酸镁;Described lubricant is selected from polyethylene glycol, sodium bicarbonate, micropowder silica gel, stearic acid or magnesium stearate;
所述助悬剂选自纤维素、蜂蜡、固态聚乙二醇或微粉硅胶;The suspending agent is selected from cellulose, beeswax, solid polyethylene glycol or micropowder silica gel;
所述润湿剂选自吐温-80、甘油、软磷脂;The wetting agent is selected from Tween-80, glycerin, lecithin;
所述溶剂选自甘油、丙二醇、植物油、液态聚乙二醇或乙醇;The solvent is selected from glycerin, propylene glycol, vegetable oil, liquid polyethylene glycol or ethanol;
所述表面活性剂选自硬脂酸、二十烷基苯磺酸钠、聚山梨酯或脂肪酸山梨坦;The surfactant is selected from stearic acid, sodium eicosylbenzenesulfonate, polysorbate or fatty acid sorbitan;
所述矫味剂选自蔗糖、香精、柠檬酸、糖精钠或阿斯巴甜。The flavoring agent is selected from sucrose, essence, citric acid, sodium saccharin or aspartame.
本发明的有益效果:Beneficial effects of the present invention:
该减肥药采用药食同源的原料,具有控制高脂饮食诱导的肥胖,缓解肥胖状态下的高脂血症,抑制肥胖状态下的高血清内毒素状态,抑制胰脂肪酶的作用,能够很好达到健康减脂目的。The weight-loss medicine uses raw materials of the same origin as medicine and food, and has the functions of controlling obesity induced by high-fat diet, alleviating hyperlipidemia in obese state, inhibiting high serum endotoxin state in obese state, and inhibiting pancreatic lipase. Good for healthy weight loss.
附图说明Description of drawings
图1砂仁不同提取物对体重的影响Figure 1 Effect of different extracts of amomum on body weight
其中,金双歧:GoldenBifid(GLB)Among them, Golden Bifid: GoldenBifid (GLB)
砂仁挥发油:VolatileOildfromFructusAmomi(VOA)Amomum volatile oil: VolatileOildfromFructusAmomi (VOA)
砂仁水提物:WaterextractfromFructusAmomi(WEA)Amomum water extract: WaterextractfromFructusAmomi (WEA)
(VOA.H)高剂量砂仁挥发油(VOA.H) High dose Amomum volatile oil
(VOA.M)中剂量砂仁挥发油(VOA.M) Medium dose Amomum volatile oil
(VOA.L)低剂量砂仁挥发油(VOA.L)Low dosage Amomum volatile oil
(WEA.H)高剂量砂仁水提物(WEA.H) High Dose Amomum Water Extract
(WEA.M)中剂量砂仁水提物(WEA.M) Medium Dose Amomum Water Extract
(WEA.L)低剂量砂仁水提物(WEA.L) Low Dose Amomum Water Extract
图2砂仁不同提取物对摄食体重比的影响Figure 2 The effect of different extracts of amomum on the ratio of food intake to body weight
图3砂仁不同提取物对甘油三酯(TG)的影响Figure 3 The effect of different extracts of Amomum on triglyceride (TG)
图4砂仁不同提取物对总胆固醇(TC)的影响Figure 4 The effect of different extracts of amomum on total cholesterol (TC)
图5砂仁不同提取物对内毒素(LPS)的影响Fig. 5 Effect of different extracts of Amomum on endotoxin (LPS)
图6砂仁不同提取物在体外对胰脂肪酶活性的影响Figure 6 Effect of different extracts of Amomum on pancreatic lipase activity in vitro
与正常组相比,*p<0.05,**p<0.01,***p<0.001Compared with normal group, * p<0.05, ** p<0.01, *** p<0.001
与模型组相比,#p<0.05,##p<0.01,###p<0.001 # p<0.05, ## p<0.01, ### p<0.001 compared to the model group
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。除非另外说明,否则所有的百分数、比率、比例或份数按重量计。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. For the experimental methods without specific conditions indicated in the following examples, usually follow the conventional conditions or the conditions suggested by the manufacturer. All percentages, ratios, proportions or parts are by weight unless otherwise indicated.
除非另行定义,文中所使用的所有专业与科学用语与本领域熟练人员所熟悉的意义相同。此外,任何与所记载内容相似或均等的方法及材料皆可应用于本发明方法中。文中所述的较佳实施方法与材料仅作示范之用。Unless otherwise defined, all professional and scientific terms used herein have the same meanings as commonly understood by those skilled in the art. In addition, any methods and materials similar or equivalent to those described can be applied to the method of the present invention. The preferred implementation methods and materials described herein are for demonstration purposes only.
实施例1:砂仁水提物颗粒剂制备Embodiment 1: Preparation of amomum aqueous extract granules
1提取方法:选取云南引种阳春砂仁(AmomunvillosumLour),粉碎后精密称取200g,加蒸馏水1000ml浸泡半小时,煮沸后文火煎10分钟,过滤药液。药渣加蒸馏水再煎煮10分钟,过滤药液,药渣加蒸馏水再煎煮5分钟,合并三次滤液,浓缩,冻干,即为砂仁水提物。1. Extraction method: Select Amomunvillosum Lour from Yunnan, crush it and weigh 200g, add 1000ml of distilled water to soak for half an hour, boil it, fry it with low heat for 10 minutes, and filter the liquid medicine. Add distilled water to the dregs of the medicine and decoct for 10 minutes, filter the liquid medicine, add distilled water to the dregs of the medicine and decoct for 5 minutes, combine the filtrates three times, concentrate, and freeze-dry, which is the water extract of Amomum japonicus.
2制剂:砂仁水提物50g、加淀粉约110g、香精约10g,按照等量递加混合均匀,制粒、分装,即得颗粒剂,5g/袋,约30袋。2. Preparation: 50g of water extract of amomum seed, about 110g of starch, about 10g of essence, mixed evenly in equal amounts, granulated and subpackaged to obtain granules, 5g/bag, about 30 bags.
实施例2:砂仁挥发油颗粒剂的制备Embodiment 2: the preparation of amomum volatile oil granule
1提取方法:选取云南引种阳春砂仁(AmomunvillosumLour),粉碎后精密称取200g置于圆底烧瓶中,加蒸馏水1200ml,浸泡1小时,采用水蒸气蒸馏法提取10h,收集挥发油。1 Extraction method: Select Amomunvillosum Lour from Yunnan, crush it, weigh 200g precisely, put it in a round bottom flask, add 1200ml of distilled water, soak for 1 hour, extract by steam distillation for 10h, and collect the volatile oil.
2制剂:砂仁挥发油50g、加蔗糖约100g、糊精约10g,按照等量递加混合均匀,制粒、分装,即得颗粒剂,5g/袋,约30袋。2 Preparation: Amomum volatile oil 50g, add about 100g sucrose, about 10g dextrin, add and mix evenly according to the same amount, granulate and pack separately to get granules, 5g/bag, about 30 bags.
实施例3:砂仁挥挥发油胶囊的制备Embodiment 3: the preparation of amomum volatile oil capsule
1提取方法:选取云南引种阳春砂仁(AmomunvillosumLour),粉碎后精密称取200g置于圆底烧瓶中,加蒸馏水1200ml,浸泡1小时,采用水蒸气蒸馏法提取10h,收集挥发油。1 Extraction method: Select Amomunvillosum Lour from Yunnan, crush it, weigh 200g precisely, put it in a round bottom flask, add 1200ml of distilled water, soak for 1 hour, extract by steam distillation for 10h, and collect the volatile oil.
2制剂:将胶囊体插入胶囊板中,将方法1制得的挥发油50g置于胶囊板上,轻轻敲动胶囊板,使药粉落入胶囊壳中,至全部胶囊壳中都装满药粉后,套上胶囊帽,0.5g/粒,共100粒。2 Preparation: Insert the capsule body into the capsule plate, put 50g of the volatile oil prepared in method 1 on the capsule plate, tap the capsule plate lightly to make the medicine powder fall into the capsule shell, until all the capsule shells are filled with the medicine powder , put on the capsule cap, 0.5g/capsule, 100 capsules in total.
实施例4:药理实验Embodiment 4: pharmacological experiment
(1)砂仁对肥胖大鼠的减重、降脂及降血清内毒素含量的效果(1) Effects of amomum on weight loss, lipid reduction and serum endotoxin content reduction in obese rats
实验用SD大鼠90只,分设正常组、模型组、砂仁挥发油(实施例2制备)(VOA)提取物低、中、高剂量(4、8、16mg/kg)给药组,砂仁水提物(实施例1制备)(WEA)低、中、高剂量(24、48、96mg/kg)给药组,益生菌金双歧(GLB)阳性对照组(450mg/kg),除正常组外,各组喂食高脂饲料(猪油10%、蛋黄10%、胆固醇1%、基础饲料79%)至实验结束。实验期间每日记录体重、进食量;每两周对所有大鼠眼内眦空腹取血,每次每只取血量约为1.5-2ml。90 SD rats were used in the experiment, and were divided into normal group, model group, low, medium and high dose (4,8,16mg/kg) administration groups of Amomum volatile oil (prepared in Example 2) (VOA) extract, Amomum Water extract (prepared in Example 1) (WEA) low, medium and high dose (24,48,96mg/kg) administration group, probiotics golden bifidum (GLB) positive control group (450mg/kg), except the normal group , each group was fed high-fat feed (10% lard, 10% egg yolk, 1% cholesterol, 79% basal feed) until the end of the experiment. Body weight and food intake were recorded daily during the experiment; blood was collected from the inner canthus of all rats on an empty stomach every two weeks, and the amount of blood collected was about 1.5-2ml each time.
所取血液用高速台式冷冻离心机以10000r/min的转速,4℃离心15min,取上清液采用甘油三酯试剂盒(GOP-POD法)、总胆固醇试剂盒(GOP-POD法)检测血清甘油三酯(TG)、总胆固醇(TC)的含量。The collected blood was centrifuged at 10,000r/min at 4°C for 15min in a high-speed desktop refrigerated centrifuge, and the supernatant was tested for serum by a triglyceride kit (GOP-POD method) and a total cholesterol kit (GOP-POD method). Triglyceride (TG), total cholesterol (TC) content.
实验12周后以水合氯醛溶液麻醉大鼠,使用一次性真空静脉采血管,采取肝门静脉血,2000r/min离心10min,取上层血浆,采用鲎试剂检测肠源性内毒素(LPS)含量。After 12 weeks of the experiment, the rats were anesthetized with chloral hydrate solution, and blood from the hepatic portal vein was collected using a disposable vacuum venous blood collection tube, centrifuged at 2000r/min for 10min, and the upper layer of plasma was taken, and the content of intestinal-derived endotoxin (LPS) was detected by Limulus reagent.
如图1所示,高脂饲料喂养SD大鼠的同时给予不同砂仁水提物,均可有效降低大鼠体重及血液中TG、TC含量,同时砂仁组摄食量与模型组接近,但体重增加不明显,摄食体重比高。其中以砂仁挥发油提取物对大鼠体重、TG、TC降低效果最为显著。高脂饲料喂养SD大鼠12周后,模型组LPS的含量显著性升高,而砂仁水提物组一定程度上抑制了LPS的升高,其中以砂仁挥发油抑制效果最为显著。结果显示,砂仁水提物及砂仁挥发油(后者效果更突出),均可明显控制高脂饮食诱导的肥胖,且能够缓解肥胖状态下的高脂血症,同时可抑制肥胖状态下的高血清内毒素状态。As shown in Figure 1, feeding SD rats with high-fat diet and giving different water extracts of Amomum can effectively reduce the body weight of the rats and the contents of TG and TC in the blood. At the same time, the food intake of the Amomum group is close to that of the model group, but The weight gain is not obvious, and the ratio of food intake to body weight is high. Among them, Amomum volatile oil extract has the most significant effect on reducing rat body weight, TG, and TC. After feeding SD rats with high-fat diet for 12 weeks, the LPS content of the model group increased significantly, while the Amomum water extract group inhibited the increase of LPS to a certain extent, among which the volatile oil of Amomum had the most significant inhibitory effect. The results showed that Amomum water extract and Amomum volatile oil (the latter effect is more prominent), can significantly control the obesity induced by high-fat diet, and can relieve the hyperlipidemia in the obese state, and at the same time inhibit the obesity in the obese state. High serum endotoxin state.
(2)砂仁对胰脂肪酶的体外抑制活性(2) In vitro inhibitory activity of amomum on pancreatic lipase
通过对砂仁挥发油、水提物及阳性药奥利司他(orlistat)对脂肪酶活性抑制的体外实验,以三酸甘油酯释放油酸为指标,评价砂仁挥发油提取物及水提物对胰脂肪酶活性作用。Through in vitro experiments on the inhibition of lipase activity by Amomum volatile oil, water extract and the positive drug orlistat, the release of oleic acid from triglycerides was used as an index to evaluate the effect of Amomum volatile oil extract and water extract on lipase activity. Pancreatic lipase activity.
配制300units/mL胰脂肪酶溶液。参照已有的报道方法制作脂肪乳剂,准确称取80mg三油酸甘油酯,10mg卵磷脂,5mg牛黄胆酸,置于干劲的小旋蒸瓶中,60℃水浴蒸干。加9mL的0.1mol/LdeTris-盐酸溶液(PH7.0),超声波处理5min,使其充分乳化。最终在反应体系中加入100uL脂肪乳剂,50uL的胰脂肪酶溶液,以及100uL的水,此为空白对照;另外反应管中加入100uL不同浓度的砂仁挥发油提取液、水提物及阳性药,为实验组。所有离心管于37℃恒温孵育30min,反应结束后,按说明书操作,使用游离脂肪酸试剂盒测定释放的脂肪酸含量,每次取样3次,取平均值表示酶活力,绘制砂仁水提物及奥利司他对胰脂肪酶活性的抑制曲线。Prepare 300units/mL pancrelipase solution. Make fat emulsion according to the existing report method, accurately weigh 80 mg triolein, 10 mg lecithin, and 5 mg taurocholic acid, place them in a dry small rotary evaporator, and evaporate to dryness in a water bath at 60 °C. Add 9mL of 0.1mol/L deTris-hydrochloric acid solution (PH7.0), ultrasonic treatment for 5min to make it fully emulsified. Finally, 100uL of fat emulsion, 50uL of pancrelipase solution, and 100uL of water were added to the reaction system, which was used as a blank control; in addition, 100uL of Amomum volatile oil extract, water extract and positive drug of different concentrations were added to the reaction tube to obtain test group. All centrifuge tubes were incubated at a constant temperature of 37°C for 30 minutes. After the reaction, operate according to the instructions, use the free fatty acid kit to measure the released fatty acid content, take 3 samples each time, take the average value to indicate the enzyme activity, and draw the water extract of Amomum japonicus and Austrian Inhibition curve of lixistat on pancreatic lipase activity.
如图6所示,以横坐标为砂仁不同提物浓度,纵坐标为胰脂肪酶的相对活力百分数,可见砂仁挥发油及水提物均对胰脂肪酶有抑制作用,且存在剂量效应,其中以砂仁挥发油抑制效果较好。可见砂仁挥发油及水提物可通过抑制肠道脂肪酶对食物中脂肪的分解,从而抑制了TG、TC的合成,进而降低体重。As shown in Figure 6, the abscissa is the concentration of different extracts of Amomum amomum, and the ordinate is the relative activity percentage of pancreatic lipase. It can be seen that both the volatile oil and water extract of Amomum amomum have an inhibitory effect on pancreatic lipase, and there is a dose effect. Among them, Amomum volatile oil has a better inhibitory effect. It can be seen that the volatile oil and water extract of amomum can inhibit the decomposition of fat in food by intestinal lipase, thereby inhibiting the synthesis of TG and TC, thereby reducing body weight.
本发明的实验数据除图1-6外,可参考下表1-4。Except for Figures 1-6, the experimental data of the present invention can refer to the following Tables 1-4.
表1砂仁不同提取物对大鼠体重的影响(g,n=10)Table 1 Amomum different extracts on rat body weight (g, n=10)
续表1Continued Table 1
与正常组相比,*p<0.05,**p<0.01,***p<0.001Compared with normal group, * p<0.05, ** p<0.01, *** p<0.001
与模型组相比,#p<0.05,##p<0.01,###p<0.001 # p<0.05, ## p<0.01, ### p<0.001 compared to the model group
表2砂仁不同提取物对大鼠摄食体重比的影响(%,n=10)Table 2 Amomum different extracts on the impact of rat food intake body weight ratio (%, n=10)
续表2Continued Table 2
表3砂仁不同提取物对大鼠TG、TC(mmol/L,n=10)及LPS(EU,n=10)含量的影响Table 3 Amomum different extracts have effect on rat TG, TC (mmol/L, n=10) and LPS (EU, n=10) The effect of content
续表3Continued Table 3
与正常组相比,*p<0.05,**p<0.01,***p<0.001Compared with normal group, * p<0.05, ** p<0.01, *** p<0.001
与模型组相比,#p<0.05,##p<0.01,###p<0.001 # p<0.05, ## p<0.01, ### p<0.001 compared to the model group
表4砂仁不同提取物在体外对胰脂肪酶活性的影响(%,n=10)Table 4 Amomum different extracts in vitro on the influence of pancreatic lipase activity (%, n=10)
以上所述仅为本发明的较佳实施例而已,并非用以限定本发明的实质技术内容范围,本发明的实质技术内容是广义地定义于申请的权利要求范围中,任何他人完成的技术实体或方法,若是与申请的权利要求范围所定义的完全相同,也或是一种等效的变更,均将被视为涵盖于该权利要求范围之中。The above description is only a preferred embodiment of the present invention, and is not intended to limit the scope of the essential technical content of the present invention. The essential technical content of the present invention is broadly defined in the scope of the claims of the application, and any technical entity completed by others or method, if it is exactly the same as that defined in the scope of the claims of the application, or an equivalent change, it will be deemed to be included in the scope of the claims.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510617335.2A CN105169203B (en) | 2015-09-25 | 2015-09-25 | A kind of Fructus Amomi extract and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510617335.2A CN105169203B (en) | 2015-09-25 | 2015-09-25 | A kind of Fructus Amomi extract and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105169203A true CN105169203A (en) | 2015-12-23 |
CN105169203B CN105169203B (en) | 2019-10-29 |
Family
ID=54891951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510617335.2A Expired - Fee Related CN105169203B (en) | 2015-09-25 | 2015-09-25 | A kind of Fructus Amomi extract and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105169203B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999022A (en) * | 2016-05-03 | 2016-10-12 | 劲牌生物医药有限公司 | Method for extracting fructus amomi volatile oil, fructus amomi flavone and fructus amomi polysaccharide by utilizing fructus amomi |
CN106943564A (en) * | 2017-04-07 | 2017-07-14 | 云南中医学院 | Alleviate the amomum fruit volatile oil soft capsule that chemotherapy causes intestinal mucosal injury |
CN107307399A (en) * | 2017-05-23 | 2017-11-03 | 广州市高纤宝健康食品有限公司 | A kind of preparation method and application of the composition of digestive integration of drinking and medicinal herbs |
CN110621328A (en) * | 2017-09-21 | 2019-12-27 | 株式会社一圆生物 | Composition for preventing, improving or treating obesity containing amomum villosum extract |
CN112608795A (en) * | 2020-11-26 | 2021-04-06 | 福建中特药业有限公司 | Fructus amomi leaf oil and water extraction-low-temperature pressure-swing extraction process method thereof |
CN113318085A (en) * | 2021-06-07 | 2021-08-31 | 云南中医药大学 | Fructus amomi tablet for improving vomiting of pregnancy reaction and preparation method thereof |
US11483900B2 (en) | 2017-09-27 | 2022-10-25 | Everwelltechnology Co., Ltd | Carbon felt heating device and method of manufacturing the same |
CN116349817A (en) * | 2023-04-07 | 2023-06-30 | 漳州卫生职业学院 | Fructus amomi solid beverage and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104351895A (en) * | 2014-10-24 | 2015-02-18 | 杨兰钦 | Spring and summer plant beverage |
CN104435973A (en) * | 2014-11-11 | 2015-03-25 | 覃海兰 | Traditional Chinese medicine formula for losing weight |
CN104784615A (en) * | 2015-03-26 | 2015-07-22 | 哈尔滨医科大学 | Traditional Chinese medicine composition for preventing and treating hyperlipidaemia, as well as preparation method and application of traditional Chinese medicine composition |
-
2015
- 2015-09-25 CN CN201510617335.2A patent/CN105169203B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104351895A (en) * | 2014-10-24 | 2015-02-18 | 杨兰钦 | Spring and summer plant beverage |
CN104435973A (en) * | 2014-11-11 | 2015-03-25 | 覃海兰 | Traditional Chinese medicine formula for losing weight |
CN104784615A (en) * | 2015-03-26 | 2015-07-22 | 哈尔滨医科大学 | Traditional Chinese medicine composition for preventing and treating hyperlipidaemia, as well as preparation method and application of traditional Chinese medicine composition |
Non-Patent Citations (4)
Title |
---|
唐灿等: ""砂仁挥发油的提取工艺"", 《华西药学杂志》 * |
彭明丽等: "《精选小化工产品配方与工艺》", 31 January 2010, 化学工业出版社 * |
李志文: "《常见病中医药调治》", 29 February 2012, 金盾出版社 * |
黄雅玲: ""砂仁、红枣、荔枝草及细本山葡萄等水萃物对调节血脂及肠道保健之探讨"", 《中兴大学食品暨应用生物科技学系所学位论文》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999022A (en) * | 2016-05-03 | 2016-10-12 | 劲牌生物医药有限公司 | Method for extracting fructus amomi volatile oil, fructus amomi flavone and fructus amomi polysaccharide by utilizing fructus amomi |
CN105999022B (en) * | 2016-05-03 | 2019-10-25 | 劲牌生物医药有限公司 | A method of amomum fruit volatile oil, fructus amomi flavones and fructus amomi polysaccharide are extracted using fructus amomi |
CN106943564A (en) * | 2017-04-07 | 2017-07-14 | 云南中医学院 | Alleviate the amomum fruit volatile oil soft capsule that chemotherapy causes intestinal mucosal injury |
CN106943564B (en) * | 2017-04-07 | 2020-07-10 | 云南中医学院 | Amomum volatile oil soft capsules for relieving chemotherapy-induced intestinal mucosal damage |
CN107307399A (en) * | 2017-05-23 | 2017-11-03 | 广州市高纤宝健康食品有限公司 | A kind of preparation method and application of the composition of digestive integration of drinking and medicinal herbs |
JP2020518282A (en) * | 2017-09-21 | 2020-06-25 | コーポレーション イルウォンバイオCorporation Ilwonbio | Therapeutic composition for preventing or ameliorating obesity containing Yangchun sand extract |
EP3603657A4 (en) * | 2017-09-21 | 2020-05-06 | Corporation Ilwonbio | Composition containing amomum villosum extract for prevention, alleviation, or treatment of obesity |
CN110621328A (en) * | 2017-09-21 | 2019-12-27 | 株式会社一圆生物 | Composition for preventing, improving or treating obesity containing amomum villosum extract |
US11483900B2 (en) | 2017-09-27 | 2022-10-25 | Everwelltechnology Co., Ltd | Carbon felt heating device and method of manufacturing the same |
CN112608795A (en) * | 2020-11-26 | 2021-04-06 | 福建中特药业有限公司 | Fructus amomi leaf oil and water extraction-low-temperature pressure-swing extraction process method thereof |
CN112608795B (en) * | 2020-11-26 | 2023-11-07 | 福建中特药业有限公司 | Fructus amomi leaf oil and water extraction-low-temperature pressure transformation extraction process method thereof |
CN113318085A (en) * | 2021-06-07 | 2021-08-31 | 云南中医药大学 | Fructus amomi tablet for improving vomiting of pregnancy reaction and preparation method thereof |
CN116349817A (en) * | 2023-04-07 | 2023-06-30 | 漳州卫生职业学院 | Fructus amomi solid beverage and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN105169203B (en) | 2019-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105169203B (en) | A kind of Fructus Amomi extract and application thereof | |
CN103371227A (en) | Pure natural beverage capable of not only perfecting dietary structure but also regulating dietary property and flavor | |
CN104431064A (en) | Blood glucose-lowering tea and preparation method thereof | |
CN1939296B (en) | Theapolyphenol composition and its preparation | |
CN108653619A (en) | A kind of medicine food formula and preparation method thereof for spleen deficiency phlegm wet blood stasis type simple obesity | |
WO2015021631A1 (en) | Astragalus seed raw oil, refined oil, preparation method therefore and application thereof | |
EP1583547A1 (en) | Anti-obesity ingretients from medicinal plants and their composittion | |
CN108403818A (en) | A kind of composition of auxiliary hyperglycemic and application thereof | |
WO2015172273A1 (en) | Pharmaceutical composition for controlling blood lipids and body weight, and use thereof | |
CN105101817B (en) | Edible composition and preparation method thereof and the food comprising said composition | |
KR101923603B1 (en) | A composition for anti-obesity comprising green tea complex extracts | |
CN107854656B (en) | A kind of lipid-lowering traditional Chinese medicine composition and its preparation method and use | |
CN110090253B (en) | A kind of natural plant lipid-lowering composition and preparation method thereof | |
CN104000876A (en) | Composition of mangnolia officinalis and gingerol and application thereof | |
CN100563678C (en) | Be used for pharmaceutical composition of liver cirrhosis and preparation method thereof | |
CN114177208A (en) | Application of custard apple seed ethanol extract in preparation of lipid-lowering and weight-losing medicine | |
CN1320881C (en) | A drop pill for treating acute and chronic hepatitis | |
CN103041288B (en) | A kind of Chinese medicine composition and preparation technology treating diabetic fatty liver | |
CN102631425A (en) | Mongolian medicine for treating dyslipidemia | |
CN109820913A (en) | Uses of Sichuan pepper oil or vine pepper oil and soft capsules | |
CN105641383A (en) | Traditional Chinese medicine lozenge with fat-reducing effect and preparation method thereof | |
CN104173683A (en) | Traditional Chinese medicine composition for treating hyperthyroidism and preparation method thereof | |
CN109481515A (en) | A kind of solid dispersions effervescent tablet promoting digestive function | |
CN103859393B (en) | A kind of food and its preparation method and application | |
CN113694105B (en) | Composition with blood fat reducing function and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191029 |